» Articles » PMID: 18435804

Establishing Humanized Mice Using Stem Cells: Maximizing the Potential

Overview
Date 2008 Apr 26
PMID 18435804
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Studies on physiology and pathology as they relate to the immune system draw heavily upon rodent models. With the increasing impetus provided by initiatives in translational medicine, the demand for ever more sophisticated, 'humanized' murine models is greater than ever. However, the design and implementation of studies in such mice is far from trivial. Here we provide a technical perspective on the increasing interest in developing humanized mice. We give examples of primary data starting with the routine procurement of human donor material, through CD34(+) cell purification prior to engraftment to injection into immunocompromised mice. Our goal is to provide practical advice to the many investigators who may be commencing or considering such studies.

Citing Articles

Humanized Mice as a Model to Assess the Response of Human Hematopoietic Stem Cells to Irradiation.

Atamanyuk N, Andreev S, Peretykin A, Styazhkina E, Obvintseva N, Tryapitsina G Bull Exp Biol Med. 2023; 176(1):34-37.

PMID: 38091132 DOI: 10.1007/s10517-023-05962-4.


Patient-derived precision cut tissue slices from primary liver cancer as a potential platform for preclinical drug testing.

Jagatia R, Doornebal E, Rastovic U, Harris N, Feyide M, Lyons A EBioMedicine. 2023; 97:104826.

PMID: 37806285 PMC: 10667128. DOI: 10.1016/j.ebiom.2023.104826.


Humanized Mouse Model of HIV Infection.

Leontyev D, Glazkova D, Bezborodova O, Tsyganova G, Urusov F, Pankratov A Bull Exp Biol Med. 2023; 175(1):63-66.

PMID: 37338766 DOI: 10.1007/s10517-023-05812-3.


Advances in Research of Adult Gliomas.

Finch A, Solomou G, Wykes V, Pohl U, Bardella C, Watts C Int J Mol Sci. 2021; 22(2).

PMID: 33477674 PMC: 7831916. DOI: 10.3390/ijms22020924.


An Improved Patient-Derived Xenograft Humanized Mouse Model for Evaluation of Lung Cancer Immune Responses.

Meraz I, Majidi M, Meng F, Shao R, Ha M, Neri S Cancer Immunol Res. 2019; 7(8):1267-1279.

PMID: 31186248 PMC: 7213862. DOI: 10.1158/2326-6066.CIR-18-0874.


References
1.
Maerten P, Kwon B, Shen C, De Hertogh G, Cadot P, Bullens D . Involvement of 4-1BB (CD137)-4-1BBligand interaction in the modulation of CD4 T cell-mediated inflammatory colitis. Clin Exp Immunol. 2006; 143(2):228-36. PMC: 1809580. DOI: 10.1111/j.1365-2249.2005.02991.x. View

2.
DiSanto J, Muller W, Fischer A, Rajewsky K . Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor gamma chain. Proc Natl Acad Sci U S A. 1995; 92(2):377-81. PMC: 42743. DOI: 10.1073/pnas.92.2.377. View

3.
Greiner D, Hesselton R, Shultz L . SCID mouse models of human stem cell engraftment. Stem Cells. 1998; 16(3):166-77. DOI: 10.1002/stem.160166. View

4.
Vassilev T, Mihaylova N, Voynova E, Nikolova M, Kazatchkine M, Kaveri S . IgM-enriched human intravenous immunoglobulin suppresses T lymphocyte functions in vitro and delays the activation of T lymphocytes in hu-SCID mice. Clin Exp Immunol. 2006; 145(1):108-15. PMC: 1942011. DOI: 10.1111/j.1365-2249.2006.03098.x. View

5.
Takenaka K, Prasolava T, Wang J, Mortin-Toth S, Khalouei S, Gan O . Polymorphism in Sirpa modulates engraftment of human hematopoietic stem cells. Nat Immunol. 2007; 8(12):1313-23. DOI: 10.1038/ni1527. View